Uncoupling RARA transcriptional activation and degradation clarifies the bases for APL response to therapies

Julien Ablain1, Magdalena Leiva, Laurent Peres

  • 1Université Paris Diderot, Sorbonne Paris Cité, France.

Insights

Retinoic acid (RA) and arsenic treat acute promyelocytic leukemia (APL) by degrading PML/RARA. New synthetic retinoids cause differentiation but not PML/RARA loss, proving degradation is essential for APL eradication.

Area of Science:

  • Hematology
  • Molecular Biology
  • Cancer Research

Background:

  • Acute promyelocytic leukemia (APL) is driven by PML/RARA.
  • Retinoic acid (RA) and arsenic are effective APL therapies.
  • The mechanism of RA's efficacy, particularly the roles of transcriptional activation versus protein degradation, is debated.

Purpose of the Study:

  • To investigate the distinct contributions of PML/RARA transcriptional activation and degradation in APL treatment.
  • To determine if differentiation alone is sufficient for APL eradication.
  • To unify the understanding of RA and arsenic mechanisms in APL.

Main Methods:

  • Synthesized novel retinoids that selectively activate RARA/PML-RARA transcription without inducing protein degradation.
  • Assessed the effects of these synthetic retinoids on APL cell differentiation, leukemia-initiating activity, and survival in mouse models.
  • Analyzed PML/RARA protein levels in differentiated APL cells from treated mice.

Main Results:

  • Synthetic retinoids induced terminal differentiation of APL cells, similar to RA.
  • These 'uncoupled' retinoids failed to degrade PML/RARA protein.
  • APL cells treated with uncoupled retinoids retained leukemia-initiating capacity, and mice showed limited survival benefit compared to RA treatment.
  • Differentiated APL cells from uncoupled retinoid-treated mice still expressed PML/RARA and could reinitiate leukemia.

Conclusions:

  • PML/RARA protein degradation, not just differentiation, is essential for eradicating APL.
  • This finding clarifies the distinct roles of transcriptional activation and proteolysis in RA and arsenic therapies.
  • Understanding these mechanisms highlights the importance of PML/RARA loss for effective APL treatment and combination therapies.

Related Concept Videos

Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
Combinatorial Gene Control02:33

Combinatorial Gene Control

Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...